Description

β-D-Erythro-Pentodialdo-1,4-Furanoside, Methyl 2-(Benzoylamino)-2,3-Dideoxy- is a sophisticated carbohydrate derivative and chiral building block of significant interest in advanced organic synthesis. This compound matters for its role as a key intermediate in the production of nucleoside analogs and other biologically active molecules, offering precise stereochemical control. Pharmaceutical research and development laboratories, as well as fine chemical manufacturers, require this high-purity intermediate to drive innovation in antiviral and anticancer therapeutic agents.

Application

• Pharmaceutical Intermediate: Critical precursor in the synthesis of novel nucleoside and nucleotide analogs for antiviral and anticancer drug discovery.
• Chiral Building Block: Used in asymmetric synthesis to construct complex sugar-modified molecules with defined stereochemistry.
• Glycochemistry Research: Serves as a specialized substrate for studying glycosylation reactions and enzyme mechanisms.
• Probe and Diagnostic Agent Development: Potential starting material for creating labeled compounds or molecular probes for biological imaging and assays.
• Academic and R&D Laboratories: Employed in methodological development and the exploration of new synthetic pathways in organic chemistry.
• Fine Chemical Production: Integrated into multi-step synthesis processes for manufacturing high-value, low-volume specialty chemicals.

Basic Information

Product Name	β-D-Erythro-Pentodialdo-1,4-Furanoside, Methyl 2-(Benzoylamino)-2,3-Dideoxy-
CAS No.	689221-52-1
Molecular Formula	C13H15NO5
Molecular Weight	265.26 g/mol
Synonyms	Methyl 2-benzamido-2,3-dideoxy-β-D-erythro-pentodialdo-1,4-furanoside; 2-Benzamido-2,3-dideoxy-β-D-erythro-pentodialdo-1,4-furanose methyl glycoside; Benzoylated D-erythro pentodialdofuranoside derivative; CAS 689221-52-1; 2-(Benzoylamino)-2,3-dideoxy-β-D-erythro-pentodialdo-1,4-furanoside methyl ester
EINECS	Contact for details

Quality Control

Every batch of this advanced intermediate is produced under strict quality management systems. We provide comprehensive Certificates of Analysis (COA) detailing purity, identity, and impurity profiles, typically determined by HPLC, NMR, and mass spectrometry. While not a bulk commodity, our synthesis and purification processes are designed to meet the exacting standards required for pharmaceutical R&D and cGMP manufacturing. Specifications and analytical data are available for review to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); therefore, the container should be kept tightly sealed in a dry environment. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Specific Rotation	Contact for details
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.